JPMorgan has adjusted its price target for Bath & Body Works (BBWI, Financial), reducing it from $47 to $41 while maintaining an Overweight rating on the shares. This revision follows a recent retail conference where the firm reassessed its projections across the department stores and specialty softlines sectors.
The Overweight rating indicates JPMorgan's belief in the potential for the stock to outperform average market returns despite the reduced price target. The adjustment reflects a broader trend of recalibration in retail expectations as market dynamics continue to evolve.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Bath & Body Works Inc (BBWI, Financial) is $44.75 with a high estimate of $65.00 and a low estimate of $32.00. The average target implies an upside of 67.96% from the current price of $26.64. More detailed estimate data can be found on the Bath & Body Works Inc (BBWI) Forecast page.
Based on the consensus recommendation from 19 brokerage firms, Bath & Body Works Inc's (BBWI, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Bath & Body Works Inc (BBWI, Financial) in one year is $40.60, suggesting a upside of 52.4% from the current price of $26.64. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Bath & Body Works Inc (BBWI) Summary page.
